Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 821 results for "Treatment For Multiple Sclerosis"

New Treatments For Multiple Sclerosis Show Promising Results
Bioresearch Online

Biogen Idec: FDA Approves Plegridy for the Treatment of Multip...

Biogen Idec on August 15 reported that the U.S. Food and Drug Administration (FDA) has approved Plegridy (peginterferon beta-1a), a treatment for people with relapsing forms of multiple sclerosis (RMS). According to a release from the company, ..., 1 day ago

EU regulator warns on possible MS drugs side effects

Aug 20 (Reuters) - Europe's drug safety regulator said multiple sclerosis treatments known as interferon beta need stronger label warnings because some patients treated with the drugs have suffered side effects affecting the kidney and other organs.
 Reuters1 day ago EU drug regulators caution: Interferon beta MS drugs may damage kidneys, other organs  MedCity News1 day ago

AWMSG recommends Bayer's Sativex to treat multiple sclerosis

The All Wales Medicines Strategy Group (AWMSG) has recommended Bayer Healthcare's Sativex Oromucosal Spray for symptom improvement in adult patients with moderate to severe spasticity due to multiple sclerosis (MS). Sativex Oromucosal Spray, which ...
 Pharmaceutical Technology2 days ago Wales Approves Cannabis-Based Medicine for MS Patients  MedIndia3 days ago Wales first Brit country to approve cannabis-based med  Millennium Post4 days ago Sativex┬« recommended by the AWMSG  Hospital Pharmacy Europe3 days ago

Biogen Stock Gains on FDA Approval of New MS Drug

Biogen Idec Inc. (Nasdaq: BIIB ) stock was up 1.6% this morning following news that the company's multiple sclerosis (MS) drug Plegridy was approved by the U.S. Food and Drug Administration on Friday. Plegridy is marketed as a longer lasting ...
 Money Morning3 days ago US FDA approves Biogen's MS drug  Bio Spectrum Asia1 day ago Biogen receives approval of treatment for multiple sclerosis patients  Canadian Business Magazine6 days ago FDA Approves Biogen's MS Drug Plegridy  Austin American Statesman6 days ago
Deccan chronicle

Soon, pill to wipe out bad memories?

Scientists have found that a drug used to treat multiple sclerosis may pave the way for a pill that can erase bad memories. Researchers have found that mice given fingolimod, a drug approved by the US Food and Drug Administration for treatment of multiple ...
 Business Standard2 months ago Pill to wipe out bad memories?  Asian Age2 months ago

UBM Plc (UBMPY: OTCQX International Premier) | Neurology Times Features Special Coverage of Multiple Sclerosis

NORWALK, Conn. , Aug. 21, 2014 /PRNewswire/ -- UBM Medica US announces that Neurology Times , a leading online community and information resource for neurologists and other healthcare providers features special coverage on multiple sclerosis , ...
 Pink Sheets11 hours ago Neurology Times Features Special Coverage of Multiple Sclerosis  Minyanville11 hours ago Features Special Coverage of Multiple Sclerosis  BioSpace8 hours ago

Expert Consensus on Disease-Modifying Therapies in MS

A growing body of evidence suggests that early control of disease activity in patients with multiple sclerosis (MS) plays a key role in preventing disability, prolonging the period of being active and engaged, and protecting quality of life. For ...
 General Medicine eJournal1 day ago Young adults more vulnerable to multiple sclerosis disease  Times of India2 months ago

Hundreds of Clinicians in Field of Spinal Cord Injury, Multiple Sclerosis and ALS Health Care to Gather in Las Vegas for Paralyzed Veterans of America's 4th Annual Health Summit + EXPO

WHO: Paralyzed Veterans of America (Summit Host) Clinicians, researchers and health care professionals in spinal cord injury and disease WHAT: Paralyzed Veterans of America (Paralyzed Veterans) will host its 4 ...
 Business Wire1 day ago Paralyzed Veterans of America's Summit + EXPO Set for August 26 to 28  Rehab Manegement6 hours ago

Biogen Strengthens MS Portfolio with Plegridy FDA Approval

Biogen Idec's ( BIIB ) shares were up slightly (0.62%) on the FDA approval of multiple sclerosis ( MS ) product, Plegridy (peginterferon beta-1a). The FDA approved Plegridy for the treatment of people with relapsing forms of multiple sclerosis ...
 Yahoo! Finance2 days ago

Global Market for Multiple Sclerosis Disease-Modifying Products to...

According to new report from BCC Research,the global market for multiple sclerosis (MS) disease-modifying products reached nearly $10.9 billion in 2013. This is estimated to grow to nearly $14.2 billion by 2018 with a compound annual growth rate ...
 PRWeb2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less